Axogen

Axogen

Yahoo Finance • 22 days ago

NZS Capital Added Axogen (AXGN) as an Optionality Position

NZS Capital, LLC, an investment management company, released its "NZS Growth Equity Strategy" second-quarter 2026 investor letter. A copy of the letter can be downloaded here. Equity markets delivered a strong performance in the second qua... Full story

Yahoo Finance • 22 days ago

Nvidia Returns to NZS Growth Fund

This article first appeared on GuruFocus. NZS Growth Equity Strategy added Nvidia (NASDAQ:NVDA) back to its portfolio during the second quarter while increasing stakes in several high-conviction technology and healthcare names. The fund... Full story

Yahoo Finance • 23 days ago

Neuronetics Appoints Nir Naor CFO; Promotes Cory Anderson To Executive VP

(RTTNews) - Neuronetics, Inc. (STIM), which provides treatment options for neurohealth disorders, announced that Nir Naor has been appointed Chief Financial Officer or CFO effective July 23, 2026. Separately, the company also promoted Co... Full story

Yahoo Finance • 23 days ago

Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes

Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experienceCory Anderson promoted to Executive Vice President and General Manager, Greenbrook effective July 1, 202... Full story

Yahoo Finance • 2 months ago

Dow Jones AI Giant Nvidia Stock Tumbles To Key Support Level Amid Market Sell-Off

Dow Jones AI giant Nvidia stock tumbled to a key support level during Tuesday's stock market sell-off. A decisive bounce would be bullish. Continue Reading... Full story

Yahoo Finance • 2 months ago

Eli Lilly Leads Medical Stocks To Watch, While Google Finds Support

Eli Lilly leads three health care stocks to watch as the market appears to be rotating into medicals. Google stock is finding key support too. Continue Reading... Full story

Yahoo Finance • 3 months ago

The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself

Issued on behalf of Conexeu Sciences Inc. A biotech debut out of Reno is betting that the next wave of medicine won’t replace tissue — it’ll grow it back. NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) -- Energy Metal News News Commentary... Full story

Yahoo Finance • 3 months ago

AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam

Key Points Interested in AxoGen, Inc.? Here are five stocks we like better. AxoGen says its core strategy remains focused on developing the peripheral nerve repair market, and CEO Michael Dale reiterated confidence in the company’s Avance... Full story

Yahoo Finance • 3 months ago

Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference

ALACHUA, Fla. and TAMPA, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced th... Full story

Yahoo Finance • 3 months ago

Sector Update: Health Care Stocks Edge Higher Late Afternoon

Health care stocks edged up late Tuesday afternoon, with the NYSE Health Care Index fractionally hig PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 months ago

AxoGen Non-GAAP EPS of $0.07 in-line, revenue of $61.46M beats by $3.69M

* AxoGen press release [https://seekingalpha.com/pr/20489863-axogen-inc-reports-first-quarter-2026-financial-results] (AXGN [https://seekingalpha.com/symbol/AXGN]): Q1 Non-GAAP EPS of $0.07 in-line. * Revenue of $61.46M (+26.6% Y/Y) be... Full story

Yahoo Finance • 4 months ago

Capricorn Fund Makes a Huge Bet on Nerve Repair With 687,000 Share Axogen (AXGN) Investment Worth $22.4 Million

What happened According to a recent SEC filing, Capricorn Fund Managers Ltd initiated a new stake in Axogen(NASDAQ:AXGN) during the first quarter of 2026. The fund acquired 687,600 shares, with an estimated transaction value of $22.36 mil... Full story

Yahoo Finance • 4 months ago

Capricorn Fund Managers Dumps $18.4 Million Worth of Waystar Stock in Q1

What happened According to an SEC filing dated April 24, 2026, Capricorn Fund Managers reduced its stake in Waystar(NASDAQ:WAY) by 692,554 shares during the first quarter of 2026. The estimated transaction value was $18.38 million, calcul... Full story

Yahoo Finance • 4 months ago

What Makes Axogen (AXGN) an Investment Bet?

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy returned 3.70% (gross) an... Full story

Yahoo Finance • 5 months ago

AxoGen Conference: AVANCE BLA Approval, Debt Paydown Fuel 2026 Growth Target of 18%+

AxoGen logo AxoGen (NASDAQ:AXGN) executives outlined a year of accelerating commercial momentum, recent balance sheet improvements, and the operational implications of its December Biologics License Application (BLA) approval for AVANCE d... Full story

Yahoo Finance • 6 months ago

AxoGen Q4 Earnings Call Highlights

AxoGen logo AxoGen (NASDAQ:AXGN) reported fourth-quarter and full-year 2025 results that management said marked a “financial inflection point,” citing accelerating adoption of the company’s nerve repair algorithm, improved operating lever... Full story

Yahoo Finance • 6 months ago

HighMark Wealth Management Buys 158,855 Shares of Axogen Stock

In its fourth-quarter 13F filing, HighMark Wealth Management LLC disclosed a purchase of 158,855 shares in Axogen(NASDAQ:AXGN) . This purchase makes the stock one of the firm’s largest holdings. What happened According to its Feb. 4, 202... Full story

Yahoo Finance • 6 months ago

Axogen (AXGN) Benefited from Multiple Tailwinds

Meridian Funds, managed by ArrowMark Partners, released its fourth-quarter 2025 investor letter for “Meridian Small Cap Growth Fund”. A copy of the letter can be downloaded here. U.S. equity markets navigated a quarter supported by optimis... Full story

Yahoo Finance • 6 months ago

Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

ALACHUA, Fla. and TAMPA, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced tha... Full story

Yahoo Finance • 8 months ago

Axogen gets FDA OK for Avance’s biologics license application

[Mature female virologist examining test tube while working in laboratory] Maskot * Axogen (AXGN [https://seekingalpha.com/symbol/AXGN]) on Wednesday said [https://seekingalpha.com/pr/20328257-axogen-announces-fda-approval-of-biologics-... Full story